Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and effectiveness of liposomal hyaluronic acid, PRP and vitamin C for under-eye rejuvenation and brightening
IRCT20200127046282N28Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of hyaluronic acid, platelet-rich plasma and ascorbic acid in infraorbital hyperchromia, sponsored by Tehran University of Medical Sciences. Primary endpoints: Safety under-eye treatment and Under-eye brightening effectiveness. Started May 2023; status: completed.
02
Drugs
hyaluronic acidplatelet-rich plasmaascorbic acid
03
Conditions
infraorbital hyperchromia
Beyond the preview
Go deeper on IRCT20200127046282N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N28.